Quarterly rpt on consolidated results for the financial period ended 31 Mar 2017

PHARMANIAGA BERHAD

Financial Year End 31 Dec 2017
Quarter 1 Qtr
Quarterly report for the financial period ended 31 Mar 2017
The figures have not been audited



Currency: Malaysian Ringgit (MYR)

SUMMARY OF KEY FINANCIAL INFORMATION
31 Mar 2017

 
INDIVIDUAL PERIOD
CUMULATIVE PERIOD
CURRENT YEAR QUARTER
PRECEDING YEAR
CORRESPONDING
QUARTER
CURRENT YEAR TO DATE
PRECEDING YEAR
CORRESPONDING
PERIOD
31 Mar 2017
31 Mar 2016
31 Mar 2017
31 Mar 2016
$$'000
$$'000
$$'000
$$'000
1 Revenue
618,294
559,195
618,294
559,195
2 Profit/(loss) before tax
27,777
26,538
27,777
26,538
3 Profit/(loss) for the period
19,258
18,470
19,258
18,470
4 Profit/(loss) attributable to ordinary equity holders of the parent
18,923
18,379
18,923
18,379
5 Basic earnings/(loss) per share (Subunit)
7.30
7.10
7.30
7.10
6 Proposed/Declared dividend per share (Subunit)
4.00
4.00
4.00
4.00


AS AT END OF CURRENT QUARTER
AS AT PRECEDING FINANCIAL YEAR END
7
 Net assets per share attributable to ordinary equity holders of the parent ($$)
2.1000
2.0500

Definition of Subunit:

In a currency system, there is usually a main unit (base) and subunit that is a fraction amount of the main unit.
Example of the subunit is as follows:

Country Base Unit Subunit
Malaysia Ringgit Sen
United States Dollar Cent
United Kingdom Pound Pence



Announcement Info

Company Name PHARMANIAGA BERHAD
Stock Name PHARMA
Date Announced 16 May 2017
Category Financial Results
Reference Number FRA-15052017-00023